MedPath

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

Conditions
Prostate Carcinoma
Interventions
Other: Non-Interventional Study
Registration Number
NCT06472817
Lead Sponsor
Mayo Clinic
Brief Summary

This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.

Detailed Description

PRIMARY OBJECTIVE:

I. To employ the social determinant of migrant health framework (International Organization for Migration, n.d.) to examine the impact of immigration on the health-seeking behaviors of SSAI including informed-decision making, psychosocial effects and coping mechanisms. (Phase I) II. To examine SDOMH factors among SSAI and CI men, including their migration experience and health behaviors. (Phase II)

OUTLINE: This is an observational study.

AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study.

AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Male
Target Recruitment
80
Inclusion Criteria
  • PHASE I:

    • Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer
    • Able to provide written consent and conduct an interview
    • Able to speak and understand English
  • PHASE II:

    • Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English
    • Able to provide written consent and conduct an interview
    • Able to speak and understand English
Exclusion Criteria
  • PHASE I:

    • Patients below the ages of 18, and those not belonging to any of four regions
    • Employees of Mayo Clinic will be excluded
    • Non-English speakers will not be included
  • PHASE II:

    • Individuals below the age of 18
    • Those not diagnosed with prostate cancer and individuals not from the regions described above
    • Employees of Mayo Clinic will be excluded
    • Non-English speakers will not be included

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ObservationalNon-Interventional StudyAIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study. AIM II: Participants complete an interview in person, over the phone, or via zoom on study.
Primary Outcome Measures
NameTimeMethod
Qualitative Interview - identification of themes and constructsBaseline

Data will be collected during an in-depth interview and will be analyzed with an inductive, open coding approach, first identifying themes, then constructs that emerge from the data will be categorized and mapped, noting new concepts and constructs. Theme convergence and divergence will be assessed. The interview guide focuses on participants' experiences and health-seeking behaviors regarding prostate cancer prevention, detection, decision-making, treatment, care, and survivorship.

Immigrant social determinants of health factors that impact Sub-Saharan African Immigrant (SSAI) carcinoma of the prostate (CaP) survivorsBaseline

From the data generated in Outcome 1 interviews, an interpretive framework or theoretical model for SSAI men will be developed to evaluate and identify factors that contribute to or exacerbate disparities in prostate cancer.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

Georgia State University

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath